2018 annual financial data
Cardiff Oncology 2018 Operating margin
Direct answer
Operating margin was -4,511.38%.
Operating income was -17,053,000 USD and net income was -16,461,000 USD.
Operating cash flow was -13,200,000 USD.
Get free Cardiff Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 378,000 USD
- Operating income
- -17,053,000 USD
- Net income
- -16,461,000 USD
- Operating cash flow
- -13,200,000 USD